title: Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness.
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
authors.forename: Miya O
authors.initials: MO
authors.lastname: Paterniti
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
authors.forename: Linda M
authors.initials: LM
authors.lastname: Breslin
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Courneya
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Sterba
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Hamilton
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.
authors.forename: Donald W
authors.initials: DW
authors.lastname: MacGlashan
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA. Electronic address: ssaini@jhmi.edu.
authors.forename: Sarbjit S
authors.initials: SS
authors.lastname: Saini
mesh_terms: D000485:Allergens / Q000276:immunology*; D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001491:Basophils / Q000166:cytology* / Q000187:drug effects; D002415:Cats; D004311:Double-Blind Method; D006632:Histamine / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D009666:Nose / Q000187:drug effects / Q000276:immunology; D000069444:Omalizumab; D012867:Skin / Q000187:drug effects / Q000276:immunology
chemical_list: D000485:Allergens; D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D006632:Histamine